The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Hepatitis B and C (HBV/HCV) coinfected patients have a potential risk of hepatitis B reactivation (HBVr) after direct-acting antivirals (DAAs) treatment. The study intends to investigate the predictive role of HBV biomarkers in HBVr. Forty-six HBV/HCV coinfected patients receiving DAAs were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Chih-Wei, Liu, Wen-Chun, Ko, Ping-Hung, Chen, Yen-Chun, Tseng, Kuo-Chih, Chang, Ting-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414824/
https://www.ncbi.nlm.nih.gov/pubmed/36016434
http://dx.doi.org/10.3390/v14081812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414824/
https://www.ncbi.nlm.nih.gov/pubmed/36016434
http://dx.doi.org/10.3390/v14081812

Ejemplares similares